Complexed PSA in routine diagnosis

Anticancer Research

Volumn 23, Issue 2 A, 2003, Pages 975-977

  Oremek, G M ^a,b   Sapoutzis, N ^a   Eden, F ^a   Jonas, D ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

cPSA; Diagnosis; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACCURACY; ADULT; AGED; CANCER DIAGNOSIS; CHEMOLUMINESCENCE; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE TUMOR;

ADULT; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; DRUG STABILITY; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REFERENCE VALUES;

EID: 0038199642     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (9)

1. Reiter W, Oberneder R and Schmeller N: Tumor markers in prostate cancer. J Lab Med 25: 337-342, 2001.
2. Semjonow A, Albrecht W, Bialk P, Gerl A, Lamerz R, Schmid H-P and Poppel von H: Tumor markers in prostate cancer. Anticancer Res 19: 2785-2820, 1999.
3. Lein M, Jung, Elgeti U et al.: Comparison of the clinical validity of free prostate-specific antigen, alpha-1-antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosis. Eur Urol 39: 57-64, 2001.
4. Lein M, Koenig F, Jung K et al.: The percentage of free prostate-specific antigen is an age-independent tumor marker for prostate cancer: establishment of reference ranges in a large population of healthy men. Brit J Urol 82: 231-236, 1998.
5. Jung K, Stephan C, Lein M et al: Analytical performance and clinical validity of two free prostate-specific antigen assays compared. Clin Chem 42: 1026-33, 1996.
6. Okihara K, Fritsche HA et al: Can complexed prostate-specific antigen and prostatic volume enhance prostate cancer detection in men with total prostate-specific antigen between 2.5 and 4.0 ng/ml? J Urol 166: 1930-1936, 2001.
7. Lym NNK, Collins GN and O'Reilly PH: Prostatic manipulation has a minimal effect on complexed prostate-specific antigen levels. B J U International 86: 65-67, 2000.
8. Wechsel HW, Gleichmann R and Blaßenek JL: The behaviour of prostate-specific antigen and free- PSA under antihormonal therapy. Anticancer Res 20: 4993-4994, 2000.
9. Oremek GM and Seiffert UB: Physical activity releases prostate-specific antigen from the prostate gland into blood and increases serum PSA concentrations. Clin Chem 42: 691-695, 1996.